Search

Your search keyword '"Bosnic-Anticevich, S."' showing total 87 results

Search Constraints

Start Over You searched for: Author "Bosnic-Anticevich, S." Remove constraint Author: "Bosnic-Anticevich, S." Database OpenAIRE Remove constraint Database: OpenAIRE
87 results on '"Bosnic-Anticevich, S."'

Search Results

1. The ARIA-MeDALL hypothesis

2. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

3. Development and validation of combined symptom-medication scores for allergic rhinitis*

4. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

5. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

6. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

7. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

8. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

9. Management of anaphylaxis due to COVID-19 vaccines in the elderly

10. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

11. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

12. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

13. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

15. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

16. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

17. ARIA-EAACI Statement on Asthma and COVID-19

18. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

19. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

20. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study

21. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

22. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes

23. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases

24. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

25. ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

26. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

27. 2019 ARIA Care pathways for allergen immunotherapy

28. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 2)

29. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

30. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

31. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?

32. 2019 ARIA Care pathways for allergen immunotherapy [ARIA-Versorgungspfade für die Allergenimmuntherapie 2019]

33. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

34. 2019 ARIA Care pathways for allergen immunotherapy

35. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

36. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: A model for multimorbid non-communicable diseases—Meeting Report (Part 1)

37. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

38. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

39. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS

40. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

41. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

42. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

43. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study

44. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

45. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

46. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study

47. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

48. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

49. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]

50. The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life:The MASK study

Catalog

Books, media, physical & digital resources